Aoxin Q&M Dental Group Ltd.

Aoxin Q&M Dental Group Ltd.

SSGX:1D4
0.16
SGD
+0.00
(-1.21%)
283.48MMarket Cap
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
- -
0.06
0.11
0.21
0.26
0.27
0.32
0.3
0.34
0.23
0.3
0.35
0.32
- -
Basic EPS, GAAP
-0.01
0.01
0.02
0.02
0.01
- -
-0.03
-0.03
-0.02
-0.11
-0.08
-0.02
0.01
- -
Free Cash Flow per Basic Share
-0.01
0.01
0.02
0.01
0.02
-0.08
-0.01
0.02
-0.01
0.02
0.02
0.05
- -
- -
Dividend per Share
- -
- -
- -
0.01
- -
0.01
- -
- -
- -
- -
- -
- -
- -
- -
Book Value per Share
-0.01
0.01
0.04
0.19
0.54
0.55
0.53
0.5
0.61
0.52
0.45
0.43
0.34
0.39
Tangible Book Value per Share
-0.02
-0.2
-0.17
-0.05
0.28
0.29
0.23
0.21
0.39
0.3
0.23
0.22
0.22
0.28
Basic Weighted Avg Shares
434
434
434
415
381
443
445
445
470
596
597
511
535
800
Sales/Revenue/Turnover
- -
25
46
87
101
119
141
133
160
140
177
177
171
- -
Operating Margin (%)
-888.72
13.13
18.86
20.85
11.1
0.76
-4.76
-3.99
-4.63
-8.91
2.66
4.72
5.67
- -
Depreciation Expense
- -
2
4
5
6
8
18
18
18
18
18
15
15
- -
Net Income, GAAP
-4
4
10
9
5
- -
-14
-12
-7
-68
-47
-8
7
- -
Effective Tax Rate (%)
- -
55.56
45.11
43.87
42.5
213.53
- -
- -
- -
- -
- -
- -
17.41
- -
Profit Margin (%)
-878.96
14.67
20.75
10.73
4.98
-0.38
-9.58
-9.13
-4.57
-48.43
-26.68
-4.51
4.08
- -
Working Capital
-6
-58
-34
-41
86
69
27
44
61
51
70
83
183
260
LT Debt
- -
- -
- -
- -
- -
- -
38
33
28
23
18
11
7
7
Total Equity
-5
61
88
95
237
246
234
223
364
311
267
259
349
453
Return on Invested Capital (%)
- -
5.94
6.35
10.98
3.86
-0.42
- -
- -
- -
- -
- -
- -
2.27
- -
Return on Capital (%)
- -
-16.06
-7.53
1.39
3.03
-0.19
- -
- -
- -
- -
- -
- -
2.45
- -
Return on Common Equity (%)
- -
- -
84.04
19.28
3.17
-0.19
-5.63
-5.29
-2.5
-20.07
-16.38
-3.04
2.3
- -

Capital Structure

CNY

•

in mil. unless spec.
Jun'25
Dec'25
Jun'26
ST Debt
6
5
3
LT Borrowings
- -
- -
- -
LT Finance Leases
9
7
7
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
597
1,023
1,157
Market Capitalization
127
935
1,487

Working Capital

CNY

•

in mil. unless spec.
Jun'25
Dec'25
Jun'26
Total Current Assets
122
209
286
Cash, Cash Equivalents & STI
67
149
223
Accounts Receivable, Net
42
41
50
Inventories
12
10
10
Total Current Liabilities
30
27
25
Payables & Accruals
- -
- -
- -
ST Debt
6
5
3
Deferred Revenue
- -
- -
- -

Growth Rates

CNY

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
21.82%
13.23%
35.03%
Free Cash Flow
-135.5%
-89.96%
-93.11%
Net Income, GAAP
319.87%
96.78%
-187.18%
Sales/Revenue/Turnover
16.5%
6.28%
-3.63%
Total Cash Common Dividend
- -
- -
- -

Semi-annual Revenue

CNY

•

in mil. unless spec.

Year

H1
H2
FY
2024
- -
- -
177
2025
- -
- -
171
2026
- -
- -
- -

Semi-annual Earnings Per Share

CNY

•

in mil. unless spec.

Year

H1
H2
FY
2024
- -
- -
-0.02
2025
- -
- -
0.01
2026
- -
- -
- -

Semi-annual Dividends Per Share

CNY

•

in mil. unless spec.

Year

H1
H2
FY
2024
- -
- -
- -
2025
- -
- -
- -
2026
- -
- -
- -

Company Description

Sector
Health services
Industry
Medical/Nursing services
Address
Singapore Singapore
IPO Date
Apr 26, 2017
Business
Aoxin Q&M Dental Group Limited is an investment holding company and a leading provider of private dental healthcare services, dental laboratory services, and dental equipment and consumables distribution in the People's Republic of China. Founded in 1997 and headquartered in Shenyang, Liaoning Province, China, the company operates primarily in northern China and functions as a subsidiary of Singapore-based Q & M Dental Group (Singapore) Limited. The company structures its operations into three core business segments: Primary Dental Services, Dental Laboratory Services, and Distribution of Dental Equipment and Supplies. Through its Primary Dental Services segment, the company operates a network of dental hospitals and polyclinics delivering general and specialized dental care, including general dentistry such as scaling, fillings, root canal therapy, and tooth extractions; restorative treatments and prosthodontics; dental implantology and oral and maxillofacial surgeries; orthodontics and malocclusion correction utilizing traditional fixed appliances and clear aligner therapies; cosmetic and aesthetic dentistry, including composite veneers and teeth whitening; and specialized paediatric dental services. Through its Dental Laboratory Services segment, the company designs, fabricates, and sells customized dental prostheses and appliances, including porcelain-fused-to-metal and all-ceramic crowns; zirconia bridges; full and partial removable dentures; orthodontic retainers; and computer-aided design and manufacturing (CAD/CAM) surgical guides. Through its Distribution of Dental Equipment and Supplies segment, the company distributes medical and dental devices, clinical instruments, diagnostic imaging equipment, and dental consumable supplies to third-party hospitals, dental polyclinics, and private practitioners. In recent developments, Aoxin Q&M Dental Group has accelerated the digitalization of its dental healthcare operations and laboratory manufacturing pipelines, deploying digital intraoral scanning systems, 3D printing technologies, and automated CAD/CAM milling infrastructure across its network to enhance diagnostic accuracy and shorten prosthetic fabrication cycles. The company has completed post-pandemic operational realignments by refocusing corporate resources on core clinical dentistry and expanding dedicated paediatric and orthodontic treatment suites within its flagship hospitals. In addition, the group has deepened supply chain synergies with parent company Q & M Dental Group (Singapore) Limited to optimize equipment procurement costs and expanded the service capacity of its established clinics across Tier-2 and Tier-3 urban markets in Liaoning Province.